uniQure N.V. Shareholders' Equity
uniQure N.V. (QURE) had Shareholders' Equity of $149.34 million as of 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-05-05
- 2026-03-31: Stockholders' Equity Attributable to Parent $149.34M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $198.90M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $228.75M.
- 2025-06-30: Stockholders' Equity Attributable to Parent -$4.00M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-03-31 | $149.34M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $198.90M 10-Q · filed 2026-05-05 |
| 2025-09-30 | $228.75M 10-Q · filed 2025-11-10 |
| 2025-06-30 | -$4.00M 10-Q · filed 2025-11-10 |
| 2025-03-31 | $33.69M 10-Q · filed 2026-05-05 |
| 2024-12-31 | -$6.75M 10-Q · filed 2026-05-05 |
| 2024-09-30 | $55.82M 10-Q · filed 2025-11-10 |
| 2024-06-30 | $97.11M 10-Q · filed 2025-11-10 |
| 2024-03-31 | $146.75M 10-Q · filed 2025-07-29 |
| 2023-12-31 | $207.67M 10-K · filed 2026-03-02 |
| 2023-09-30 | $268.78M 10-Q · filed 2024-11-05 |
| 2023-06-30 | $353.32M 10-Q · filed 2024-11-05 |
| 2023-03-31 | $412.77M 10-Q · filed 2024-08-01 |
| 2022-12-31 | $476.01M 10-K · filed 2026-03-02 |
| 2022-09-30 | $421.17M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $486.49M 10-Q · filed 2023-11-07 |
| 2022-03-31 | $546.00M 10-Q · filed 2023-08-01 |
| 2021-12-31 | $595.78M 10-K · filed 2025-02-27 |
| 2021-09-30 | $590.75M 10-Q · filed 2022-11-02 |
| 2021-06-30 | $633.61M 10-Q · filed 2022-11-02 |
| 2021-03-31 | $228.69M 10-Q · filed 2022-08-08 |
| 2020-12-31 | $243.91M 10-K · filed 2024-02-28 |
| 2020-09-30 | $227.89M 10-Q · filed 2021-10-25 |
| 2020-06-30 | $265.50M 10-Q · filed 2021-10-25 |
| 2020-03-31 | $295.15M 10-Q · filed 2021-07-26 |
| 2019-12-31 | $323.06M 10-K · filed 2023-02-27 |
| 2019-09-30 | $350.23M 10-Q · filed 2020-10-27 |
| 2019-06-30 | $132.06M 10-Q · filed 2020-10-27 |
| 2019-03-31 | $157.11M 10-Q · filed 2020-07-30 |
| 2018-12-31 | $179.61M 10-K · filed 2022-02-25 |
| 2018-09-30 | $199.85M 10-Q · filed 2019-10-28 |
| 2018-06-30 | $218.42M 10-Q · filed 2019-10-28 |
| 2018-03-31 | $100.26M 10-Q · filed 2019-07-29 |
| 2017-12-31 | $89.36M 10-K · filed 2021-03-01 |
| 2017-09-30 | $19.61M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $27.29M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $45.73M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $63.63M 10-K · filed 2020-03-02 |
| 2015-12-31 | $127.93M 10-K · filed 2019-02-28 |
| 2014-12-31 | $42.63M 10-K · filed 2018-03-14 |
| 2013-12-31 | $2.29M 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |